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ABSTRACT
Objectives: Hypertrophic cardiomyopathy (HCM) represents a generalized myopathic process affecting
both ventricular and atrial myocardium. We assessed the global and regional left atrial (LA) function
and its relation to left ventricular (LV) mechanics and clinical status in patients with HCM using Vector
Velocity Imaging (VVI).
Methods: VVI of the LA and LV was acquired from apical four- and two-chamber views of 108 HCM
patients (age 40 ^ 19years, 56.5% men) and 33 healthy subjects, all had normal LV systolic function.
The LA subendocardium was traced to obtain atrial volumes, ejection fraction, velocities, and strain
(e)/strain rate (SR) measurements.
Results: Left atrial reservoir (esys,SRsys) and conduit (early diastolic SRe) function were significantly
reduced in HCM compared to controls (P, .0001). Left atrial deformation directly correlated to LVesys,
SRsys and negatively correlated to age, NYHA class, left ventricular outflow tract (LVOT) gradient, left
ventricular mass index (LVMI), LA volume index and severity of mitral regurge (P,0.001). Receiver
operating characterist was constructed to explore the cutoff value of LA deformation in differentiation
of LA dysfunction; esys , 40% was 75% sensitive, 50% specific, SRsys , 1.7s
21 was 70% sensitive, 61%
specific, SRe . 21.8s
21 was 81% sensitive and 30% specific, SRa . 21.5s
21 was 73% sensitive and
40% specific. By multivariate analysis global LVesys and LV septal thickness are independent predictors
for LAesys, while end systolic diameter is the only independent predictor for SRsys, P, .001.
Conclusion: Left atrial reservoir and conduit function as measured by VVI were significantly impaired
while contractile function was preserved among HCM patients. Left atrial deformation was greatly
influenced by LV mechanics and correlated to severity of phenotype.
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INTRODUCTION
Hypertrophic cardiomyopathy (HCM) is a familial disease with an autosomal dominant pattern of
inheritance caused by mutations in genes encoding for sarcomeric proteins. The condition usually
results in a hetrogenous myopathic disease affecting both the ventricular and atrial myocardium [1,2].
It is thought to be a progressive disease that most often begins with left ventricular (LV) diastolic
dysfunction and/or structural remodeling of the atria, including chamber enlargement and interstitial
fibrosis [3]. Better understanding of atrial structure and function could lead to improvements in
identifying early signs of diastolic impairment, heart failure and to enhanced prediction of risk related
to the development of atrial fibrillation (AF). Such enhanced knowledge would also allow practitioners
to better estimate the response to treatments in patients with this arrhythmia.
Noninvasive assessment of structure and function of the atria has been limited by a lack of
suitable methods for making these measurements. Left atrial (LA) dysfunction is mostly diagnosed
by mitral and pulmonary vein Doppler echocardiography. A complementary method is tissue Doppler
imaging (TDI), which more directly estimates myocardial tissue velocities and thus provides a
relatively load-independent measure of function [4]. The addition of maximal LA volume may improve
diagnostic accuracy [5].
The atrium has multiple functions, acting as a reservoir and a conduit in addition to its contractile
function. Thus, there is a need for a more detailed analysis of its pathophysiological importance, and
accordingly, for techniques that may supplement available technology in identifying early signs of
mechanical impairment.
Recently, 2-dimensional (2D) strain and strain rate (SR) measurements from grayscale images have
been introduced based on speckle tracking (SPT), a method in which ultrasound speckles within the
image are tracked and strain is determined from the displacement of speckles in relation to each
other. The method provides an angle-independent parameter of myocardial function [6,7]. A new
feature-tracking echocardiographic method using vector velocity imaging (VVI) is achieved through the
combination of SPT, mitral annulus motion, tissue-blood border detection, and the periodicity of the
cardiac cycle using R-R intervals. It can measure myocardial strain, SR, and velocity of the regional
endocardium [8]. Because VVI tracks moving tissue the area or volume changes in the investigated
heart chamber can be calculated automatically frame by frame. 2D-derived LA strain rate facilitates
comprehensive evaluation of LA contractile, reservoir, and conduit function.
The aim of the present study was to explore left atrial myocardial properties using VVI as a method to
quantify and detect global and regional LA dysfunction and its relation to LV mechanics and clinical
status in patients with HCM.
PATIENTS AND METHODS
Study population
HCM group
Between January 2011 and March 2012, we prospectively included 108 HCM patients between the ages
of 8 and 70 years, who were referred to our echocardiographic laboratories for risk stratification. They
were examined in a single center (Yacoub Research Unite, Menoufiya University, Egypt and as a part of
the BA-HCM National Program). Patients were enrolled in the study after their informed consent, and
approval of Ethics Committee of Menoufiya University Hospitals was obtained.
The diagnosis of HCM was based on conventional echocardiographic demonstration of a non-
dilated, hypertrophic LV ($15mm) in the absence of other cardiac or systemic diseases capable of
producing the magnitude of hypertrophy evident, [2] all patients have sinus rhythm and normal
ejection fraction (EF% . 55%). Exclusion criteria were diabetes mellitus, arterial hypertension, and
evidence of coronary artery disease, atrial fibrillation, lung disease, and inadequate echocardiograms.
Control group
We studied 33 age- and sex-matched healthy subjects without detectable cardiovascular risk factor or
receiving any medication. Volunteer controls were all selected from departments of pediatric and adult
cardiology among subjects investigated for work eligibility.
Conventional echocardiography
Echocardiographic exams were performed in the left lateral decubitus, in the parasternal long,
short-axis, apical two- and four-chamber views using standard transducer positions. Esaote Mylab
Gold 30 ultrasound system (Esaote S.p.A, Florence, Italy) equipped with a multi-frequency 2.5–3.5MHz
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phased-array transducer was utilized [8,9]. Left ventricular end diastolic (EDD), end systolic diameter
(ESD), septum(ST), posterior wall thickness (PWT), ejection fraction (EF%) and LA diameter and volume
were measured in accordance with the recommendations of the American Society of Echocardiography
[2]. Color flow mapping and continuous-wave Doppler were used to define resting left ventricular
outflow tract obstruction (LVOTO) and to estimate pulmonary artery pressure (PAP) from tricuspid
regurgitation velocity (Bernolli equation). Peak early (E) and late (A) transmitral (E and A) filling
velocities were measured from mitral inflow velocities. Peak systolic (Sm), early diastolic (Em) and atrial
diastolic (Am) velocity as well as isovolumetric relaxation time (IRT) were obtained by placing a pulsed
tissue Doppler (TDI) sample volume at the lateral mitral annulus in the apical four-chamber view. From
this, the E/Em ratio was calculated.
Analysis of LA and LV deformation
Border tracking of the LA and LV was manually traced from the digitized 2D video clips recorded during
breath holding and with good quality ECG signals, which were acquired and stored for off-line analysis
using XStraine software with a frame rate between 40–80 fps. The ‘‘Zoom/RES’’ feature on the
echocardiographic machine was used to improve the accuracy of atrial measurements. A circular
region of interest was traced on the endocardial cavity interface of the apical four-chamber view at end
diastole (LA minimum cavity area) using a point-and-click approach. Time-volume curves were
extracted from LA wall tracking that provided automatically indexed maximum and minimum LA
volume and left atrium ejection force (LAEF) [5,6]. We measured longitudinal (LNG) peak velocities
achieved by LA walls 1 cm above the mitral annulus in systole (Sam), early (Eam) and late diastole (Aam).
Definition of the LA endocardial border enabled the system to calculate regional longitudinal
deformation of the LA walls. Peak systolic strain (esys) and LA systolic SR (SRsys) were measured as a
positive curve at LV systole (representing reservoir function), early diastole (SRe) (representing conduit
function), and atrial diastole (SRa) (representing contractile function). Image processing algorithm
automatically subdivides the atrial wall into 12 segments distributed in septum and lateral and
posterior LA wall–“roof”. The graphs for each segment were displayed and averaged to calculate
global LA function [10] (Figure 1, 2).
For LV deformation, the same parameters were measured for the basal, mid and apical segments of
the septal, lateral, anterior and inferior wall, from apical four and two-chamber views. To reduce
random noise, each sample was obtained by averaging three consecutive heart cycles.
Figure 1. LA strain and strain rate using VVI. A: Curved M-mode of LA longitudinal strain. B: Tracing of the LA
endocardial border in apical 4-ch view showing velocity vectors. C: Strain and D: strain rate versus time curves in
septal, lateral and LA roof segments. The averaged LA SRsys is 1.9 s
21.
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To estimate mechanical dyssynchrony, the index of myocardial systolic activation was calculated
from regional strain curves for each segment, as time from the beginning of a Q wave of ECG to the
peak LNG esys (TTP). Left atrial and LV electromechanical delay were measured as the difference
between TTP (d-TTP) in 12 LA and 12 LV segments, respectively (difference between the longest and
shortest cycle) [10,11]. Intra-atrial and intra-ventricular dyssynchrony were defined as the standard
deviation of the averaged time-to-peak strain (TTP-SD) [12,13].
Inter and Intra-observer variability
Two independent observers performed two separate quantitative esys and SR analyses of LA and
LV images blindly in 35 participants. Inter-observer and intra-observer agreement for esys data was:
for LV esys, R ¼ 0.87 and 0.92, LA esys, R ¼ 0.89 and 95, TTP, R ¼ 0.89 and 0.95, respectively; and
SRsys, inter-observer R ¼ 0.88, intra-observer R ¼ 92. Both inter and intra-observer agreements were
lower for diastolic SR. For SRe: R ¼ 0.84 and 0.87, respectively and for SRa: R ¼ 0.82 and 0.85,
respectively.
Statistical analyses
Data were presented as numbers (%) or as mean and standard deviation values. The distribution
of qualitative variables was analyzed by Chi-Square test or Fisher’s exact test. Quantitative variables
were correlated by the use of Pearson’s correlation coefficient “r.” All tests were two-tailed, and a
P value , 0.05 was considered statistically significant. To identify significant independent predictors
of global LA strain and SR, variables that were statistically significant in univariate analysis were
introduced in a multivariate regression model; the overall fitness of the model was evaluated with
the calculation of the coefficient R þ SE. Receiver operating characteristic (ROC) curve analysis was
performed to select optimal cut-off values of LA deformation measurements. The analysis was
performed by the IBM SPSS statistics software package [19].
Figure 2. Assessment of LA wall velocity using VVI. A: Curved M-mode of LA longitudinal velocity. B: Tracing of
the LA endocardial border in apical 4-Ch view showing velocity vectors. C: longitudinal. D: Transverse velocity–
time curves from LA segments. (Sa: atrial systolic velocity, Ea: early atrial diastolic velocity, Aa: atrial late
diastolic velocity).
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RESULTS
Clinical characteristics of the study population (Table 1)
There were no significant differences between the HCM and control group in terms of average age,
gender, BSA, heart rate or blood pressure. (Q1)Of 108 HCM patients, 47 (43.5% females) and 72 (66.7%)
were symptomatic; , 63% are NYHA class II, 33% class III, 4% class IV, and 8 (7%) had a history
of syncope. Forty (37%) were familial type (based on prospective evaluation of relatives), 16 (15%)
had a positive family history of premature sudden death. Eighty-four (,78%) had asymmetric septal
hypertrophy, 20 (19%) had concentric LVH, and 3(,3%) had apical HCM. Twenty-three (21%) patients
had extreme LVH (MWT $ 30mm), 26 (24%) had LVOTO $ 30mmHg, 57 (53%) had LA volume
index . 30m/m2, 3% had severe tricuspid regurgitation, and 22 (20%) had PAP . 30mmHg
(range: 30–82mmHg).
Conventional echocardiographic analysis
There was no significant difference between the two groups in LV EF%, Em inflow velocity. Left atrial
dimension, volume index, ST and PWT, LVMI and LVOT gradiant, Am inflow velocity, were significantly
greater, whereas left ventricular end-systolic diameters (LVESD), left ventricular end diastolic diameter
(LVEDD), Em/Am were significantly reduced in HCM group (P, .001). E/Em was significantly elevated
when compared to control (P, .001) (Table 1).
LV deformation analysis (Table 1)
In HCM, 2D strain analysis detected lower global and regional peak LA esys, SRsys and SRe(P, .001)
at the level of all analyzed segments in comparison to control. Despite the significant difference
of SRa at some segmental levels, LV global atrial diastolic SR did not differ from control. Similarly,
electromechanical delay (d-TTP) and intra-V dyssynchrony was considerably prolonged between
LV segments compared with its corresponding segments in healthy individuals (P, .001).
Regional and Global LA function (Table 2)
As compared to healthy subjects, HCM patients had lower LNG peak LA wall velocities Sam, Eam and Aam
P, .001. Similar findings were observed for regional and averaged LA wall esys (P,0.001) and for
reservoir and conduit function derived by SR measured during the systolic and early diastolic period
(P, .001). Contrarily, LA contractile function, as expressed by SR measured during late diastole,
remains conserved and did not differ between the studied groups (P, .0001) (Table 4). Left atrial
volumes were significantly increased (P, .01, .003) and left atrial ejection force (LAEF) estimated
by time volume curve was significantly reduced in HCM compared with control (P, .001).
For electromechanical delay between LA segments, controls showed homogeneous systolic
activation of the atrial walls. Conversely, the HCM group showed significant delay between segments
(d-TTP; P, .001) and dispersion of electromachanical activation between LA segments (TTP-SD:
46.5 ^ 38.2 vs. 29.9 ^ 21, P, .001).
Univariate relations of LA 2Dstrain indexes: (Table 3 and Figures 3,4,5,6)
In HCM, the deformation variables estimated by LA esys and SR were concordant with those derived by
LNG LA velocities measured by tissue Doppler (P, .0001). LA global strain was directly correlated to LA
SRsys (r ¼ .86, P, .0001), both were directly related to LV esys, SRsys and SRe, EF%, LAEF% (P, .0001),
and inversely related to age, positive family history, LA volume index, MWT, LVMI, MR severity
(P, .0001), LVOT gradient (P, .006), LVESD (P, .008), and intra-A dyssynchrony (TTP-SD, P, .001),
respectively. We also observed correlations between LA wall deformation parameters and peak mitral
annulus velocities measured by pulsed TDI (P, .0001).
To explore the cutoff points that discriminate LA dysfunction, we constructed ROC curves for LA esys,
SRsys,SRe and SRa in HCM (Figure 7). For atrial reservoir function; LA esys , 40% shows 75% sensitivity
and 50% specificity respectively. AUC: 0.733 [CI: 0.649 – .819, P, .0001], SRsys , 1.7 s
21 shows 70%
sensitivity and 61% specificity with AUC 0.727[CI: 0.643– 0.811, P, .0001]. For conduit function; (SRe),
cutoff value .21.8 s21 shows 81% sensitivity and only 31% specificity (good screening test).
In addition, the atrial contractile function as estimated by LA SRa . 21.5 s
21 shows 73% sensitivity
and 40% specificity respectively.
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Table 1. Clinical and echocardiographic characteristics of study population.
HCM (n ¼ 108) Control (n ¼ 30) P value*
Age (years) 40.7 ^ 19.1 38.2 ^ 17.4 Ns.
Female sex 47 (43.5%) 11 (33.3%) Ns.
BSA 1.8 ^ 0.36 1.85 ^ 0.16 Ns.
Heart rate (b/min) 70.6 ^ 8.7 75.1 ^ 9.9 Ns.
SBP (mmHg) 130 ^ 18.1 120 ^ 9 Ns.
DBP (mmHg) 84.2 ^ 12.8 81 þ 6.5 Ns.
LA diameter (mm) 37.4 ^ 9.1 30.4 ^ 4.5 0.001
LA volume index (ml/m2) 35.2 ^ 18 12 ^ 8.7 0.001
SAM (%) 20 (20%)
LVOTO 57 (53%)
Mitral regurge:
no 5 (2%) 30 (100%)
Trivial & mild 75(70%)
Moderate 21 (21%)
Severe 7 (7%) Ns.
LVESD (mm) 21.8 ^ 6.7 33.2 ^ 5.7 0.001
LVEDD (mm) 32.9 ^ 5.6 45.7 ^ 6.7 0.001
EF% 71.2 ^ 11.5 64.4 ^ 10.4 Ns.
MWT (mm) 25.6 ^ 7 9.7 ^ 2 0.001
ST (mm) 24.5 ^ 6.7 9.8 ^ 2.2 0.001
PWT (mm) 14.6 ^ 4.2 9.7 ^ 2.1 0.001
LVMI (gm/m2) 222 ^ 94 112 ^ 32 0.001
LVOT gradient (mmHg) 27 ^ 42 2.9 ^ 1.2 0.002
Mitral E (m/sec) 0.67 ^ 0.35 0.76 ^ 0.13 0.001
Mitral A (m/sec) 0.96 ^ 0.35 0.52 ^ 0.13 0.001
Mitral E/A 0.68 ^ 0.62 1.2 ^ 0.13 0.001
PAP (mmHg) 28.9 ^ 16.3 12.3 ^ 2.2 0.01
Em Lateral (cm/s) 9.5 ^ 3.9 11.3 ^ 3.4 0.001
AmLateral (cm/s) 9.8 ^ 3.6 8.3 ^ 2.9 0.001
SmLateral (cm/s) 8.4 ^ 1.2 11.2 ^ 2.3 0.001
E/Em 12 ^ 7.7 6.2 ^ 3.8 0.001
Left ventricular deformation
Global LV esys% 29.1 6 6.6 220.5 6 1.3 0.001
LV d-TTP 200 6 115 69 6 50 0.001
TTP-SD 63.9 6 37.2 29.2 6 16.4 0.001
Global LV SRsys s
21 20.77 6 0.35 21.28 6 0.21 0.001
Global LV SRe s
21 0.81 6 0.53 1.57 6 0.3 0.001
Global LV SRa s
21 0.59 6 1.18 0.62 6 0.11 Ns.
*Chi-Square test/student’s test
Ns.¼non-significant
BSA: body surface area
SBP: systolic blood pressure
DBP: diastolic blood pressure
LVH: left ventricular hypertrophy
SAM: systolic anterior motion
LVOTO left ventricular outflow tract obstruction
LVESD: left ventricular end-systolic diameter
LVEDD: left ventricular end-diastolic diameter
EF: ejection fraction
MWT: maximal wall thickness
PWT: posterior wall thickness
ST: septal thickness
LVMI: left ventricular mass index
E: early mitral inflow velocity
A: atrial mitral inflow velocity
DT: deceleration time
PAP: pulmonary artery pressure;
Em: mitral annulus early diastolic velocity
Am: mitral annulus atrial diastolic velocity
Sm: mitral annulus systolic velocity
esys: peak systolic strain
LV: left ventricle
TTP: time to peak strain
d-TTP: delay between TTP
TTP-SD: standard deviation of time to peak strain
SRsys: peak systolic strain rate
SRe: early diastolic strain rate
SRa: atrial diastolic strain rate
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Multivariate analysis
Stepwise forward, multiple linear regression analyses were performed in the overall population to
weigh the independent associations between LA esys/SR and clinical status and LV phenotype.
By this model, after adjusting for potential determinants, for reservoir function; global LV SRsys
(b coefficient ¼ 0.624; CI at 95%: 0.289– 0.77) and LV septal thickness (b coefficient 0.773;
CI at 95%: 0.355–0.78), P, .0001 are independent predictors for global LA strain, and only LV end
systolic diameter is an independent predictor for SRsys (b coefficient 0.033; CI at 95%: 0.015–0.083),
P, .03. For atrial conduit function; LA EF (b coefficient 5.27; CI at 95%: 3.24–7.45, P, .001 is
independent predictor of SRe.
DISCUSSION
The central finding of our study is a quantitative assessment of LA function in patients with HCM. The LA
reservoir and conduit function derived by VVI is significantly compromised while LA contractile function
is preserved in HCM with normal ejection fraction. Global LA 1sys and SR is strongly related to functional
class and severity of phenotypic expression. Moreover, LV SRsys and septal thickness are independent
predictors to LA 1sys in patients with HCM.
Atrial function is an integral part of cardiac function that is often neglected. The recognition of the
upper limits of atrial size and function in HCMmay be of clinical relevance by assisting in distinguishing
cardiac remodeling and help with patients’ risk stratification [1,2].
Table 2. Left atrial deformation.
HCM (n ¼ 108) Control (n ¼ 33) P value*
esys % LA septum 26.9 ^ 18.5 41.5 ^ 14.3 0.001
esys% LA lateral 29.8 ^ 19.2 45.5 ^ 10.8 0.001
esys% LA roof 29.5 ^ 12.8 40.3 ^ 8.8 0.001
esys% Global LA 28.4 6 17.5 43.7 6 9.9 0.001
PSS (no.of seg) 1.22 ^ 1.56 0
Mean TTP (ms) 409 ^ 111 416 ^ 63 NS
LA d-TTP (ms) 108 ^ 82 48 ^ 21 0.001
LA TTP-SD (ms) 46.5 6 38.2 29.9 6 21 0.001
SRsys s
21 LA septum 1.4 ^ 0.67 1.89 ^ 0.62 0.001
SRsys s
21 LA lateral 1.52 ^ 0.76 1.92 ^ 0.62 0.006
SRsys s
21 LA roof 1.1 ^ 0.57 1.70 ^ 0.52 0.001
SRsys s
21 Global LA 1.43 6 0.68 1.92 6 0.62 0.001
SRe s
21 LAseptum 21.06 ^ 0.95 21.48 ^ 0.86 0.02
SRe s
21 LA lateral 21.2 ^ 0.81 21.71 ^ 0.67 0.001
SRe s
21 LA roof 20.87 ^ 0.81 21.37 ^ 0.77 0.001
SRe s
21 Global LA 21.13 6 0.79 21.6 6 0.69 0.003
SRa s
21 LA septum 21.25 ^ 0.93 21.52 ^ 0.77 NS
SRa s
21 LA lateral 21.27 ^ 1.05 21.27 ^ 0.39 NS
SRa s
21 LA roof 21.01 ^ 0.83 21.22 ^ 0.97 NS
SRa s
21 Global LA 21.25 6 0.86 21.39 6 0.46 NS
Sam (cm/s) Septal 4.7 ^ 2.7 7.9 ^ 2.7 0.001
Eam (cm/s) Septal 4.2 ^ 3.3 6.5 ^ 3.1 0.001
Aam (cm/s) Septal 3.9 ^ 2.7 5.1 ^ 2.5 0.02
Sam (cm/s) lateral 5.3 ^ 2.7 7.3 ^ 2.3 0.001
Eam (cm/s) Lateral 4.9 ^ 3.4 7.1 ^ 3.1 0.001
Aam(cm/s) lateral 4.1 ^ 2.7 5.4 ^ 2.3 0.008
Eam/Aam LA 1.4 ^ 1.3 1.7 ^ 1.8 NS
LAVI max (ml) 96.4 ^ 56 72 ^ 22 0.01
LAVI min (ml) 59 ^ 48 33 ^ 17 0.003
LAEF % 40 ^ 17 56 ^ 11 0.001
LA: left atrium
TTP: time to peak strain
d-TTP: delay between TTP
TTP-SD: standard deviation of time to peak strain
SRsys: peak systolic strain rate
SRe: early diastolic strain rate
SRa: atrial diastolic strain rate
Sam: peak systolic atrial velocity
Eam: peak early diastolic atrial velocity
Aam: peak late diastolic atrial velocity
LAVI max: LA indexed maximum volume
LAVI min: LA indexed minimum volume
LAEF: LA ejection fraction
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In the present study we applied VVI, [13,14] that allows for a multidirectional analysis of myocardial
motion in an angle-independent fashion, to explore the possibility of improving the diagnosis of early
LA dysfunction beyond that accomplished by traditional Doppler echocardiography and TDI. The
results of the present study demonstrate the usefulness of VVI in analyzing LA myocardial function in
patients with HCM. In this study, besides LA volume measurements, which showed significant increase
in HCM, and LA strain analysis, phasic LA SR was used to describe the three components of atrial
function that provided incremental information pertaining to LA function [15].
LA function in HCM
The LA operates as a reservoir and conduit compartment for blood flow from the pulmonary veins to LV
and as a contracting chamber enhancing LV filling [13]. Left atrial reservoir function is critical for LV
Table 3. Correlation between left atrial deformation, clinical and other echocardiographic
parameters.
LA esys
Global
LATTP-
SD delay
LASRsys
Global
LA diaSRe
Global
LA diaSRa
Global
Age r 2 .215 .162 2 .165 .293 2 .021
P .011 .057 .057 .000 .803
NYHA r .214 .104 2 .104 .374 2 .025
P .013 .178 .178 .000 .479
LA TPP-SD r .352 .262 .282 2 .131 2 .156
P .000 .002 .001 .122 .064
LA volume index (ml/m2) r 2 .429 .299 2 .419 .358 .207*
P .000 .000 .000 .000 .014
EF% r .187 .114 .204 .205 .008
P .026 .179 .016 .015 .928
MWT (mm) r 2 .450 .371 2 .45 .419 .210*
P .000 .000 .000 .000 .012
LVMI (g/m2) r 2 .444 .331 2 .438 .387 .284**
P .000 .000 .000 .000 .001
LVOT gradient (mmHg) r 2 .233 .046 2 .146 .244 .054
P .006 .592 .086 .004 .527
Positive FH r 2 .314 .126 2 .310 .201 .101
P .000 .141 .000 .017 .236
Global LV esys (%) r .589 .291 .538 .459 .232**
P .000 .000 .000 .000 .006
LV TPP -SD r 2 .013 2 .084 2 .009 .020 .126
P .884 .325 .915 .811 .140
Global LV SRsys r .562 .222 .530 .459 .294
**
P .000 .008 .000 .000 .000
Global LV SRe dia r .512 2 .239** .442 .459 .185*
P .000 .005 .000 .000 .029
Global LV SRa dia r .080 .007 .115 .022 .240**
P .344 .935 .174 .796 .004
LAEF% r .701 2 .142 .648 .510 .505**
P .000 .093 .000 .000 .000
E/Em r 2 .278 2 .076 2203 2 .213 .135
**
P .001 .233 .015 .008 .058
MR r 2 .282 .087 2 .279 .250* .245*
P .004 .382 .004 .011 .013
esys: peak systolic strain
LA: left atrium
TTP-SD: standard deviation of time to peak strain
LVESD: left ventricular end-systolic diameter
LVEDD: left ventricular end-diastolic diameter
EF%: ejection fraction
MWT: maximal wall thickness
LVMI: left ventricular mass index
LVOT: left ventricular outflow tract
PAP: pulmonary artery pressure
LV: left ventricle
TTP-SD: standard deviation of time to peak strain
SRsys: peak systolic strain rate
SRe: early diastolic strain rate
SRa: atrial diastolic strain rate
LAEF%: LA ejection fraction
Sam: peak systolic atrial velocity
Eam: peak early diastolic atrial velocity
Aam: peak late diastolic atrial velocity
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Table 4. Left atrial deformation using VVI in other pathological states.
Mean
LA 1 (%)
Mean LA
SR (s-1)
LA E SR
diastole (s-1)
LA A SR
diastole (s-1)
Jarnert et al.
European Journal of
Heart Failure (2008) [13]
DM & diastolic
dysfunction
No (n ¼ 60) 30.0 (7.6) 1.2 (0.4) 21.2 (0.6) 21.0 (0.5)
Mild ( ¼ 13) 25.5 (6.9) 1.9 (3.3) 20.8 (0.3) 21.1 (0.5)
Moderate ( ¼ 14) 24.1 (4.4) 1.1 (0.3) 20.9 (0.4) 20.7 (0.3)
Moustafa et al.
European Journal of
Echo. 2011 [22]
Controls (n ¼ 41) 36.9 (24.4) 0.88 þ 0.89
Mild MR (n ¼ 23) 25.9 (10.3) 0.74 þ 0.77
Moderate/
severe
MR (n ¼ 20)
23.8 (12.1) 0.54 þ 0.63
Kuppahally et al.
Circ Cardiovasc
Imaging. 2010 [30]
Paroxysmal
AF (n ¼ 24)
41.5 (14) 1.85(.9)
Persistent
AF (n ¼ 31)
31 (16) 1.6(.8)
D’Andrea et al. Br J
Sports Med 2008 [31]
Control (n ¼ 25) 47.3 (15.6)
Hypertensive
(n ¼ 40)
37.2 (17.6)
Athletes
(n ¼ 45)
51.3 (17.9)
Mean LA
e: left atrial strain
LA SR: left arterial systolic strain rate
LA E SR diastole: let atrial early diastolic strain rate
LA A SR diastole: left atrial strial diastolic strain rate
DM: diabetes mellitus
MR: mitral regurgitation
AF: atrial fibrillation
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Figure 3. Global LA systolic strain (esys) and LV esys in HCM group.
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Figure 4. Global LA systolic strain (esys) and LV end systolic diameter in HCM.
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filling by conserving energy during ventricular systole, emitted after MV opening [16,17]. This phase is
influenced by atrial compliance, atrial contraction, and LV basal systolic descent [17,18].
During the LA reservoir period, maximal positive LA strain occurs at the end of LV systole,
representing a measure of the maximal stretching of LA. Left atrial peak lengthening during ventricular
systole—represented by positive strain and SR—are important indicators of LA compliance [16–19].
Several authors have recently shown that LA esys, could be used as an index of LA reservoir function
[20–22]. In view of that, our study verified that LA esys was significantly correlated to LA SRsys and gave
similar relationship to LV function and LV phenotype.
In our cohort, quantification of longitudinal myocardial LA deformation during this phase showed
significant reduction in HCM, which was strongly related to LA volume index, LV mass index in addition
to LV systolic deformation as measured by global LV esys and SR. Meanwhile, LA reservoir was
inversely correlated to severity of mitral regurgitation. As previously documented, chronic MR provokes
volume overload, LA remodeling and impairment of LA elastic properties and compliance with
subsequent elevation of LA pressure and could intensify the deterioration of reservoir function in HCM
patients, [22–25] as was the case in the current study in which 98% displayed mild to severe mitral
regurgitation.
Left atrial esys decreased linearly with the increasing severity of LV diastolic dysfunction, as
expressed by Em, Am using TDI and LV filling pressure estimated by E/Em. Consequently, LA esys
emerged as a promising variable for the expression of the intrinsic LA function when investigating
patients with different stages of diastolic dysfunction. In the case of HCM, myocardial hypertrophy,
disarray and fibrosis are associated with increased stiffness or noncompliance of the LV, and LA
pressure rises to maintain adequate LV filling. The resultant increased atrial wall tension leads to
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Figure 5. LA systolic SR (SRsys) and LA volume in HCM.
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Figure 6. Relationship of LA early diastolic SR (SRe) and NYHA class in HCM.
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chamber dilation and stretch of the atrial myocardium [26,27]. This explains why, early in the course of
disease, LA stiffness increases whereas the LA booster pump is augmented causing work mismatch.
This is could explain the preserved contractile function (SRa) in our studied HCM population and might
imply incipient LV dysfunction in patients with apparently normal LV ejection fraction.
Left atrial conduit function, which reflects passive LV filling in early diastole, is predominantly
governed by the rate of LV relaxation [15,16]. In this study, evidence of impaired conduit function in our
HCM patients was manifested by decreased transmitral E wave and mitral annular Em velocity. Using
VVI indices, passive emptying LA velocity (Eam) and SR during early diastole (SRe) showed significant
reduction compared with the controls. This reduction in conduit function is worse with increased
severity of hypertrophy and presence of LVOTO and is associated with pulmonary hypertension. It is
firmly related to LV diastolic function as measured by deformation indexes.
Atrial booster pump function, which reflects atrial contraction at end-diastole, and is seen as
negative SR, is controlled by preload, afterload, and contractility [28,29]. In our study of HCM patients,
indexes of LA booster pump function were preserved and did not differ from control. In addition to LA
SRa, LA systolic function has been evaluated utilizing a variety of indicators, such as transmitral
Doppler flow (A), and TDI of the mitral annulus during atrial systole (Am) which showed augmented
values in relation to control. Nonetheless, the main inconvenience in the later parameters was their
high sensitivity to autonomic status, loading conditions, and LV systolic function [9,10].
The present study clarified that the deformation in the atria is reciprocally related to the deformation
of the ventricles, both reflecting the motion of the atrio-ventricular plane. In systole, the ventricle
shortens while the atria expand. This is a function of ventricular contraction. In early diastole, there is
elongation of the ventricles and shortening of the atria; the active constituent of this is the ventricular
relaxation. While in late diastole, the active component is the atrial contraction. In our HCM cohort, LA
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reservoir and conduit function deteriorated due to reduction of LV deformation as measured by VVI. At
the same time, LA contractile function remained intact in patients without evidence of heart failure.
LA functions in previous studies
Previous reports have already noted that newer applications of echocardiography, such as strain
imaging, may be a useful technique to evaluate LA myocardial function in different pathological states
(13,22,30,31).
In agreement with our results, Ros¸ca et al [32] investigated 34 HCM with speckle tracking and
reported that peak LAe and SR parameters were significantly reduced and related to LV dysfunction.
Left atrial booster pump function emerged as an independent correlate of heart failure symptoms.
Paraskevaidis et al [27] quantified LA longitudinal function by TDI and 2D strain in 43 HCM
patients—21 patients with non-HCM LVH, and 27 healthy volunteers. Left atrial longitudinal function is
reduced in HCM compared to non-HCM LVH and healthy controls. Adding 2D contractile atrial strain to
atrial diameter and volume index, inter-ventricular septal thickness, and E/A ratio and E/E0 ratios
increased its prognostic value in differentiating HCM from non-HCM LVH (p, .001). The authors
concluded that 2D atrial is more reproducible and less time consuming than TDI strain.
Additionaly, Shin et al [33] reported that through using real-time 3D echocardiography the maximal
LA volume index was larger, and LA active emptying fraction was lower in 26 HCM patients when
compared with control subjects, and the increased LA volume was related to decreased LA contraction
in HCM. LA passive emptying was related to LV relaxation whereas LA active contraction was related to
LV stiffness.
Myocardial function using VVI
Unlike previous methodology, we explored in this study indices of LV systolic and diastolic function
using VVI acquired from the LV myocardium. We believe that this approach represents a new paradigm
in evaluating LV function because it is based on measurements obtained directly from the ventricular
myocardium and not mitral recordings during early LV filling. Therefore, problems related to annular
and valvular pathology can be circumvented. Second, we obtained an index that was derived from all
LV segments and is therefore more representative of global LV performance than classic EF%.
In this study we evaluated LA function quantification and assessed the characteristics of LA regional
segments especially in presence of remodeling and dilation. Left atrial roof necessitates an angle-
independent method; in addition, the very thin LA wall posed challenges to pure SPT techniques while
VVI simplified the automated endocardial border tracking and resulted in a LA time-volume curve
generated from volume measurements at every frame.
In the present study, analysis of LA deformation raises the question about its relationship with other
functional parameters; surprisingly we found obvious relationships with TDI parameters but not with
mitral inflow velocities, which may indicate on more load-dependent and “autonomic” LA function.
Clinical implications
This study provides further insight into the influence of HCM on mechanical function. Our figures and
cutoff values put forward that LA deformation indices could be considered both diagnostic and
prognostic adjuncts that facilitate unmasking of incipient myocardial dysfunction in HCM. We
recommend serial measurement of LA strain/SR to detect the onset of LA contractile dysfunction and
impaired LA compliance, known to take place in more advanced disease. These indices may prove to
be useful in treatment decision making; however, the significance of these findings and their possible
application will require further study.
STUDY LIMITATIONS
Good quality images are needed as VVI is based on 2D grayscale imagery, leading to exclusion of many
patients from the study. The myocardial deformation is 3D but, at present, VVI permits only 2D images.
The use of DICOM data with relatively low frame rates might be challenging and less reproducible,
which may question the feasibility of this method in standard clinical practice. Only longitudinal
function parameters were explored in this study. Vector velocity imaging can potentially quantify
circumferential and radial deformation, but we found it difficult to track the acoustic kernels associated
with circumferential and radial movement of the thin LA wall from the apical position. Additionally, the
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influence of myectomy in our cohort, with LVOT obstruction, on LA function has not been studied. The
reported LV reverse remodeling following this operation, [34] could, in theory, have an effect on atrial
function. Finally, the relatively small sample size may preclude strong statistical inference. However,
we excluded patients who had recordings that could not be adequately interpreted; accordingly,
the results are representative of a population among whom it is possible to use the VVI technique.
CONCLUSION
Left atrial reservoir and conduit function as measured by VVI-derived strain/strain rate is significantly
impaired while contractile function is preserved in HCM patients with normal systolic function. Left
atrial deformation is greatly influenced by LV mechanics and correlated to severity of phenotype.
Vector velocity imaging has a discriminative power as a single measure to detect LA dysfunction
in HCM.
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